Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, Axim Biotechnologies Inc increased its cash reserves by 230.92%, or 109.18k. Cash Flow from Financing totalled 1.14m or 2,883.81% of revenues. In addition the company used 1.03m for operations while cash from investing was breakeven.
Cash flow per share | -0.0117 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.0324 |
---|---|
Tangible book value per share | -0.0439 |
More ▼
Balance sheet in USDView more
Current ratio | 0.0031 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼